Literature DB >> 14729613

Identification of the E1A-regulated transcription factor p120 E4F as an interacting partner of the RASSF1A candidate tumor suppressor gene.

Sarah L Fenton1, Ashraf Dallol, Angelo Agathanggelou, Luke Hesson, Jalal Ahmed-Choudhury, Shairaz Baksh, Claude Sardet, Reinhard Dammann, John D Minna, Julian Downward, Eamonn R Maher, Farida Latif.   

Abstract

Epigenetic inactivation of the candidate tumor suppressor gene RASSF1A is a frequent and critical event in the pathogenesis of many human cancers. The RASSF1A protein contains a Ras association domain, suggesting a role in Ras-like signaling pathways, and has also been implicated in cell cycle progression. However, the preliminary data suggests that the RASSF1A gene product is likely to have multiple functions. To identify novel RASSF1A functions, we have sought to identify interacting proteins by yeast two-hybrid analysis in a human brain cDNA library. We identified the E1A-regulated transcription factor p120(E4F) as a RASSF1A interacting partner in yeast and mammalian cells, and demonstrated that RASSF1A protein and p120(E4F) form a complex in vivo. The interaction between RASSF1A and p120(E4F) was confirmed by both in vitro and in vivo pull downs and coimmunoprecipitation assays. In addition, specific inactivation of RASSF1A by short interfering RNA disrupts binding of RASSF1A to p120(E4F) in coimmunoprecipitation assays. In addition, we demonstrated enhanced G(1) cell cycle arrest and S phase inhibition by propidium iodide staining of p120(E4F) in the presence of RASSF1A. As p120(E4F) has been reported previously to interact with p14ARF, retinoblastoma, and p53, these findings provide an important link between the function of RASSF1A and other major human tumor suppressor genes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14729613     DOI: 10.1158/0008-5472.can-03-2622

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  The E4F protein is required for mitotic progression during embryonic cell cycles.

Authors:  Laurent Le Cam; Matthieu Lacroix; Maria A Ciemerych; Claude Sardet; Piotr Sicinski
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

2.  The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex.

Authors:  Min Sup Song; Su Jung Song; So Yeon Kim; Hyun Jung Oh; Dae-Sik Lim
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

3.  The Ras effector RASSF2 controls the PAR-4 tumor suppressor.

Authors:  Howard Donninger; Luke Hesson; Michele Vos; Kristin Beebe; Laura Gordon; David Sidransky; Jun Wei Liu; Thomas Schlegel; Shannon Payne; Arndt Hartmann; Farida Latif; Geoffrey J Clark
Journal:  Mol Cell Biol       Date:  2010-04-05       Impact factor: 4.272

4.  E4F1: a novel candidate factor for mediating BMI1 function in primitive hematopoietic cells.

Authors:  Jalila Chagraoui; Sherry L Niessen; Julie Lessard; Simon Girard; Philippe Coulombe; Martin Sauvageau; Sylvain Meloche; Guy Sauvageau
Journal:  Genes Dev       Date:  2006-08-01       Impact factor: 11.361

5.  Menin determines K-RAS proliferative outputs in endocrine cells.

Authors:  Chester E Chamberlain; David W Scheel; Kathleen McGlynn; Hail Kim; Takeshi Miyatsuka; Juehu Wang; Vinh Nguyen; Shuhong Zhao; Anastasia Mavropoulos; Aswin G Abraham; Eric O'Neill; Gregory M Ku; Melanie H Cobb; Gail R Martin; Michael S German
Journal:  J Clin Invest       Date:  2014-08-18       Impact factor: 14.808

Review 6.  Tumor suppressor C-RASSF proteins.

Authors:  Hiroaki Iwasa; Shakhawoat Hossain; Yutaka Hata
Journal:  Cell Mol Life Sci       Date:  2018-01-20       Impact factor: 9.261

7.  Transcription factor E4F1 is essential for epidermal stem cell maintenance and skin homeostasis.

Authors:  Matthieu Lacroix; Julie Caramel; Perrine Goguet-Rubio; Laetitia K Linares; Soline Estrach; Elodie Hatchi; Geneviève Rodier; Gwendaline Lledo; Carine de Bettignies; Amélie Thépot; Céline Deraison; Karim Chébli; Alain Hovnanian; Pierre Hainaut; Pierre Dubus; Claude Sardet; Laurent Le Cam
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-18       Impact factor: 11.205

8.  E4F1-mediated control of pyruvate dehydrogenase activity is essential for skin homeostasis.

Authors:  Perrine Goguet-Rubio; Berfin Seyran; Laurie Gayte; Florence Bernex; Anne Sutter; Hélène Delpech; Laetitia Karine Linares; Romain Riscal; Cendrine Repond; Geneviève Rodier; Olivier Kirsh; Jawida Touhami; Jean Noel; Charles Vincent; Nelly Pirot; Guillaume Pavlovic; Yann Herault; Marc Sitbon; Luc Pellerin; Claude Sardet; Matthieu Lacroix; Laurent Le Cam
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-12       Impact factor: 11.205

9.  E4F1 controls a transcriptional program essential for pyruvate dehydrogenase activity.

Authors:  Matthieu Lacroix; Geneviève Rodier; Olivier Kirsh; Thibault Houles; Hélène Delpech; Berfin Seyran; Laurie Gayte; Francois Casas; Laurence Pessemesse; Maud Heuillet; Floriant Bellvert; Jean-Charles Portais; Charlene Berthet; Florence Bernex; Michele Brivet; Audrey Boutron; Laurent Le Cam; Claude Sardet
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-12       Impact factor: 11.205

10.  Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons.

Authors:  Frederic J Reu; Douglas W Leaman; Ratan R Maitra; Soo In Bae; Leonid Cherkassky; Mark W Fox; Donald R Rempinski; Normand Beaulieu; A Robert MacLeod; Ernest C Borden
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.